SCHEMBL633391

SCHEMBL633391

CC1=Nc2c(ccc3c(S(=O)(=O)O)cc(S(=O)(=O)O)cc23)C1(C)C

nearest known ligand 0.33

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MPL P40238 6/20 0.33
CYP2C9 P11712 2/20 0.33
CYP1A2 P05177 1/20 0.33
ALDH1A1 P00352 2/20 0.33
CYP2C19 P33261 1/20 0.33
CASP6 P55212 1/20 0.33
HSD17B10 Q99714 1/20 0.33
FOLH1 Q04609 1/20 0.32
TIMP3 P35625 1/20 0.31
SUMO2 P61956 1/20 0.30
SUMO1 P63165 1/20 0.30
SENP7 Q9BQF6 1/20 0.30
SENP2 Q9HC62 1/20 0.30
CTRC Q99895 1/20 0.30
ENPP2 Q13822 1/20 0.30
HIF1A Q16665 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4437128 0.84 ALDH1A1 (0.35) CYP2C9CYP1A2ALDH1A1CYP2C19CASP6
SCHEMBL4885961 0.81 TTR (0.43) MPLCYP1A2ALDH1A1HSD17B10SUMO2
SCHEMBL137432 0.80 RXRA (0.30)
SCHEMBL136734 0.80 MEN1 (0.44) CYP2C9CYP1A2ALDH1A1CYP2C19CASP6
Potassium SCHEMBL4171863 0.80 TTR (0.42) MPLCYP1A2ALDH1A1HSD17B10SUMO2
SCHEMBL4255042 0.80 MPL (0.40) MPLCYP2C9CYP1A2ALDH1A1CYP2C19
SCHEMBL14695213 0.79 MEN1 (0.43) CYP2C9CYP1A2ALDH1A1CYP2C19CASP6
SCHEMBL29331370 0.77 ALDH1A1 (0.31) CYP2C9ALDH1A1CYP2C19CASP6HSD17B10
SCHEMBL23961228 0.73 RXRA (0.33) ALDH1A1
SCHEMBL101082 0.73 MYC (0.36) CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10442930-B2 Biocompatible N, N-disubstituted sulfonamide-containing fluorescent dye labels VISEN MEDICAL, INC. (US) 2019-10-15 US disclosed
EP-2419478-B1 FLUORESCENT IMAGING WITH SUBSTITUTED CYANINE DYES LI COR INC (US) 2018-02-28 EP disclosed
US-20170283617-A1 Biocompatible N, N-Disubstituted Sulfonamide-Containing Fluorescent Dye Labels VISEN MEDICAL, INC. 2017-10-05 US disclosed
EP-2630196-B1 CYANINE DYES AND THEIR CONJUGATES LI COR INC (US) 2017-09-06 EP disclosed
US-9574085-B2 Biocompatible N, N-disubstituted sulfonamide-containing fluorescent dye labels VISEN MEDICAL, INC. (US) 2017-02-21 US disclosed
EP-1934211-B1 BIOCOMPATIBLE N, N-DISUBSTITUTED SULFONAMIDE-CONTAINING FLUORESCENT DYE LABELS VISEN MEDICAL INC (US) 2017-01-11 EP disclosed
US-9408924-B2 Bioconjugates of cyanine dyes LI-COR, INC. (US) 2016-08-09 US disclosed
US-20150119553-A1 BIOCONJUGATES OF CYANINE DYES LI-COR, INC. 2015-04-30 US disclosed
US-8927719-B2 Cyanine dyes and their conjugates LI-COR, INC. (US) 2015-01-06 US disclosed
US-20130274452-A1 CYANINE DYES AND THEIR CONJUGATES MIDCAP FINANCIAL TRUST 2013-10-17 US disclosed
EP-2630196-A1 CYANINE DYES AND THEIR CONJUGATES LI-COR, INC. (US) 2013-08-28 EP disclosed
US-8481752-B2 Fluorescent imaging with substituted cyanine dyes LI-COR, INC. (US) 2013-07-09 US disclosed
WO-2012054749-A1 CYANINE DYES AND THEIR CONJUGATES LI-COR, INC. (US) 2012-04-26 WO disclosed
EP-2419478-A2 FLUORESCENT IMAGING WITH SUBSTITUTED CYANINE DYES LI-COR, INC. (US) 2012-02-22 EP disclosed
US-20100323389-A1 FLUORESCENT IMAGING WITH SUBSTITUTED CYANINE DYES LI-COR, INC. (US) 2010-12-23 US disclosed
WO-2010121163-A2 FLUORESCENT IMAGING WITH SUBSTITUTED CYANINE DYES LI-COR, INC. (US) 2010-10-21 WO disclosed
US-20090130024-A1 Biocompatible N, N-Disubstituted Sulfonamide-Containing Fluorescent Dye Labels VISEN MEDICAL, INC. 2009-05-21 US disclosed
EP-1934211-A1 BIOCOMPATIBLE N, N-DISUBSTITUTED SULFONAMIDE-CONTAINING FLUORESCENT DYE LABELS Visen Medical, Inc. (US) 2008-06-25 EP disclosed
WO-2007028037-A1 BIOCOMPATIBLE N, N-DISUBSTITUTED SULFONAMIDE-CONTAINING FLUORESCENT DYE LABELS VISEN MEDICAL, INC. (US) 2007-03-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170283617-A1 Biocompatible N, N-Disubstituted Sulfonamide-Containing Fluorescent Dye Labels DNPEP, FUT5, NES MPL 4700/4885CYP2C9 4304/4885CYP1A2 4526/4885
US-20090130024-A1 Biocompatible N, N-Disubstituted Sulfonamide-Containing Fluorescent Dye Labels DNPEP, FUT5, NES MPL 4700/4885CYP2C9 4304/4885CYP1A2 4526/4885
US-20130274452-A1 CYANINE DYES AND THEIR CONJUGATES FCGR3B, QPCT, TIE1 MPL 4422/4885CYP2C9 689/4885CYP1A2 1397/4885
US-20100323389-A1 FLUORESCENT IMAGING WITH SUBSTITUTED CYANINE DYES MSR1, TIE1, ALG1 MPL 4110/4885CYP2C9 1183/4885CYP1A2 1991/4885
US-20150119553-A1 BIOCONJUGATES OF CYANINE DYES FCGR3B, FCGR2A, HCCS MPL 4040/4885CYP2C9 362/4885CYP1A2 515/4885
US-10442930-B2 Biocompatible N, N-disubstituted sulfonamide-containing fluorescent dye labels DNPEP, FUT5, NES MPL 4700/4885CYP2C9 4304/4885CYP1A2 4526/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.